Sustainable Insight Capital Management LLC Has $3.91 Million Stake in Humana Inc. $HUM

Sustainable Insight Capital Management LLC lessened its holdings in shares of Humana Inc. (NYSE:HUM) by 40.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 15,996 shares of the insurance provider’s stock after selling 10,746 shares during the quarter. Humana accounts for approximately 1.8% of Sustainable Insight Capital Management LLC’s holdings, making the stock its 20th largest holding. Sustainable Insight Capital Management LLC’s holdings in Humana were worth $3,911,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Pekin Hardy Strauss Inc. raised its stake in shares of Humana by 3.7% in the 2nd quarter. Pekin Hardy Strauss Inc. now owns 34,587 shares of the insurance provider’s stock valued at $8,456,000 after purchasing an additional 1,246 shares during the period. Savant Capital LLC grew its position in shares of Humana by 22.1% in the 2nd quarter. Savant Capital LLC now owns 13,485 shares of the insurance provider’s stock valued at $3,297,000 after acquiring an additional 2,438 shares during the period. Achmea Investment Management B.V. raised its stake in Humana by 6.2% in the second quarter. Achmea Investment Management B.V. now owns 11,019 shares of the insurance provider’s stock valued at $2,694,000 after buying an additional 640 shares during the period. Resona Asset Management Co. Ltd. lifted its holdings in Humana by 4.7% during the 2nd quarter. Resona Asset Management Co. Ltd. now owns 44,788 shares of the insurance provider’s stock valued at $10,933,000 after purchasing an additional 1,993 shares during the last quarter. Finally, Asahi Life Asset Management CO. LTD. boosted its holdings in shares of Humana by 9.1% during the second quarter. Asahi Life Asset Management CO. LTD. now owns 1,560 shares of the insurance provider’s stock worth $381,000 after acquiring an additional 130 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently commented on HUM. Morgan Stanley lowered their price target on shares of Humana from $290.00 to $277.00 and set an “equal weight” rating on the stock in a research report on Thursday, July 31st. Truist Financial set a $300.00 price objective on Humana in a report on Tuesday, October 14th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Humana in a research note on Wednesday, October 8th. Guggenheim reaffirmed a “buy” rating on shares of Humana in a research note on Friday, October 3rd. Finally, Sanford C. Bernstein upped their price objective on shares of Humana from $269.00 to $341.00 and gave the company an “outperform” rating in a report on Friday, September 5th. Eight investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $299.22.

Humana Stock Performance

Shares of HUM stock opened at $251.70 on Friday. Humana Inc. has a fifty-two week low of $206.87 and a fifty-two week high of $315.35. The stock’s 50-day moving average is $279.09 and its two-hundred day moving average is $258.85. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. The firm has a market cap of $30.27 billion, a P/E ratio of 19.32, a PEG ratio of 1.71 and a beta of 0.42.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, beating the consensus estimate of $2.95 by $0.29. The business had revenue of $32.65 billion during the quarter, compared to analysts’ expectations of $31.99 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The firm’s quarterly revenue was up 11.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $4.16 EPS. Analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, December 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.4%. Humana’s dividend payout ratio is currently 27.17%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.